Vedanta Biosciences Overview

  • Founded
  • 2010
Founded
  • Status
  • Private
  • Employees
  • 105
Employees
  • Latest Deal Type
  • Series D
  • Latest Deal Amount
  • $68M
Latest Deal Amount
  • Investors
  • 28

Vedanta Biosciences General Information

Description

Developer of immunotherapies designed to treat immune-mediated and infectious diseases. The company's immunotherapies include vast proprietary datasets from human interventional studies and facilities compliant manufacturing of rationally defined bacterial consortia in powder form to select pharmacologically potent strains, thereby enabling physicians to access oral therapies to treat autoimmune and inflammatory diseases efficiently.

Contact Information

Website
www.vedantabio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 19 Blackstone Street
  • Cambridge, MA 02139
  • United States
+1 (857) 000-0000

Vedanta Biosciences Timeline

2019202020212022
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Vedanta Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Later Stage VC (Series D) 21-Jul-2021 $68M 00000 Completed Clinical Trials - Phase 2
12. Secondary Transaction - Private 16-Apr-2021 00000 Completed Clinical Trials - Phase 2
11. Grant 30-Sep-2020 000.00 00000 Completed Clinical Trials - Phase 2
10. Debt - General 16-Sep-2020 0000 00000 Completed Clinical Trials - Phase 2
9. Grant 05-Dec-2019 00.00 00000 Completed Clinical Trials - Phase 2
8. Later Stage VC (Series C2) 23-Sep-2019 000.00 00000 00000 Completed Clinical Trials - Phase 2
7. Later Stage VC (Series C) 13-May-2019 000.00 000.00 00000 Completed Clinical Trials - Phase 2
6. Grant 10-Jul-2018 0000 Completed Clinical Trials - Phase 2
5. Grant 02-Nov-2017 $4.5M $50M Completed Clinical Trials - Phase 2
4. Later Stage VC (Series B) 06-Jun-2016 $50M $50M 00000 Completed Clinical Trials - Phase 2
To view Vedanta Biosciences’s complete valuation and funding history, request access »

Vedanta Biosciences Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series C2 000,000 00.000000 000.00 000.00 00 000.00 0.000
Series C 0,000,000 00.000000 000.00 000.00 00 000.00 00.000
Series B 2,305,948 $0.000100 $22.65 $22.65 1x $22.65 16.96%
Series A1 4,000,000 $0.000100 $1 $1 1x $1 29.42%
To view Vedanta Biosciences’s complete cap table history, request access »

Vedanta Biosciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of immunotherapies designed to treat immune-mediated and infectious diseases. The company's immunotherapies in
Drug Discovery
Cambridge, MA
105 As of 2021
00000
00000000000 00000

0000000

dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore m
0000 000000000
Madison, WI
00 As of 0000
000.00
000000000 - 000.00

00000000

am, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute iru
0000 000000000
San Diego, CA
00 As of 0000
00000
0000 0000-00-00
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Vedanta Biosciences Competitors (40)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Stemina Biomarker Discovery Venture Capital-Backed Madison, WI 00 000.00 000000000 - 000.00
000000000 Venture Capital-Backed San Diego, CA 00 00000 00000000000 00000
00000 Formerly VC-backed Ness Ziona, Israel 000 00000 000000000 00000
00000 00000000000 Formerly VC-backed Cambridge, MA 00 00000 000000000 00000
00000000 Venture Capital-Backed Paris, France 00 00000 00000000000 00000
You’re viewing 5 of 40 competitors. Get the full list »

Vedanta Biosciences Patents

  • 30

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 2

    Granted

  • 4

    Pending

  • 000

    Expiring in next 12 mo

Vedanta Biosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2019321681-A1 Methods of decreasing dysbiosis and restoring a microbiome Pending 17-Aug-2018 0000000000
EP-3836946-A1 Methods of decreasing dysbiosis and restoring a microbiome Pending 17-Aug-2018 0000000000
US-20200368293-A1 Compositions and methods for the treatment of cancer Pending 18-Jan-2018 000000000
EP-3723776-A2 Compositions and methods for suppressing pathogenic organisms Pending 11-Dec-2017 000000000
US-20200405775-A1 Compositions and methods for suppressing pathogenic organisms Pending 11-Dec-2017 A61K39/02
To view Vedanta Biosciences’s complete patent history, request access »

Vedanta Biosciences Executive Team (21)

Name Title Board Seat Contact Info
Bernat Olle Ph.D Co-Founder, Chief Executive Officer & Board Member
Mark Mullikin Chief Financial Officer
Daniel Couto Chief Operating Officer
Simona Levi Ph.D Chief Legal Officer & Corporate Secretary
Maggie McGuigan Senior Director of Finance
You’re viewing 5 of 21 executive team members. Get the full list »

Vedanta Biosciences Board Members (14)

Name Representing Role Since
Atsushi Shiota Vedanta Biosciences Board Observer 000 0000
Bennett Shapiro MD PureTech Health Board Member 000 0000
Bernat Olle Ph.D Vedanta Biosciences Co-Founder, Chief Executive Officer & Board Member 000 0000
Bharatt Chowrira Ph.D PureTech Health Board Member 000 0000
Chris Chen Vedanta Biosciences Board Observer 000 0000
You’re viewing 5 of 14 board members. Get the full list »

Vedanta Biosciences Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Vedanta Biosciences Investors (28)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Fosun Health Capital Corporate Venture Capital Minority 000 0000 000000 0
Magnetar Capital Hedge Fund Minority 000 0000 000000 0
Reimagined Ventures Family Office Minority 000 0000 000000 0
Skyviews Life Science Corporation Minority 000 0000 000000 0
Verition Fund Management Hedge Fund Minority 000 0000 000000 0
You’re viewing 5 of 28 investors. Get the full list »

Ready to get started?

Request a free trial